Descovy

Descovy is a combination medication containing emtricitabine and tenofovir alafenamide, used for HIV treatment. This oral medication helps manage HIV infection by reducing viral load.

Descovy is primarily used in the treatment of HIV-1 infection in adults and adolescents. It works by reducing the amount of HIV in the body, helping to control the infection. This medication is often prescribed as part of a comprehensive treatment plan that includes other antiretroviral drugs. Descovy is not a cure for HIV but helps manage the condition and improve quality of life.

Common effects of Descovy may include nausea, diarrhea, headache, and fatigue. Some individuals may experience changes in liver function or bone density. It is important to discuss any persistent or severe side effects with a healthcare provider.

Descovy should be used with caution in individuals with kidney or liver problems. Regular monitoring of kidney function and liver enzymes is recommended. Pregnant women or those planning to become pregnant should consult a healthcare provider before using this medication.

Descovy may interact with other medications, including those that affect kidney function or liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using Descovy.